Elizaveta K. Semeryanova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Elizaveta K. Semeryanova has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Aleksander F. Lazarev
Altai State Medical University, Ministry of Health of Russia
2 shared publications - Igor V. Vikhlyanov
Altai Regional Oncology Dispensary, Ministry of Health of Russia
2 shared publications - Irina M. Zakharova
Altai Regional Oncology Dispensary, Ministry of Health of Russia; Altai State Medical University, Ministry of Health of Russia
2 shared publications - A. V. Arefeva
Altai State Medical University, Ministry of Health of Russia
1 shared publication - Alena N. Zhuravleva
Clinical Hospital "Russian Railways-Medicine" of Barnaul", Russia
1 shared publication Anna A. Nalivaiko
Clinical Hospital "Russian Railways-Medicine" of Barnaul", Russia
1 shared publication
Latest Publications
- 9 June 2026
- Published by Publishing House ABV Press in Head and Neck Tumors (HNT)
- Vol. 16 (1) , 76-83
Prediction of thyroid cancer based on a multifactorial logistic model and the distribution of the linear predictor
Introduction. Altai region has high incidence of thyroid cancer (TC) which served as motivation for development of a multivariable logistic prognostic model based on clinical and amnestic patient data with determination of low, intermediate, and high risks of the disease. The use of the model in clinical practice can promote optimization of examination volume and formation of priority groups for in-depth diagnostics. Aim. To evaluate diagnostic value of a multivariable logistic model for TC prognosis and analyze distribution of a linear predictor in various clinical groups for identification of areas of low, intermediate and high risks. Materials and methods. Single-center retrospective study including 1463 patients with diseases of the thyroid was conducted. The main group consisted of 505 sequentially examined and surgically treated patients with morphologically confirmed TC; the control group included 958 patients without oncological pathology of the thyroid (operated due to suspicion of a tumor with subsequent morphological exclusion and selected during prophylactic examinations). The set of clinical-anamnestic, anthropometric, and phenotypic characteristics was formed based on the results of previously published study on TC risk factors in the Altai population. Using survey patient data, a set of characteristics Х1–X26 was composed. Statistical analysis included descriptive statistics, univariate logistic analysis with categorization of quantitative variables per ROC criteria, as well as development of a multivariate logistic model with stepwise predictor selection. For the final model, χ2 test, area under the ROC curve (AUC), sensitivity and specificity at optimal threshold were assessed; internal validation was performed using the bootsrap method. For clinical interpretation, distribution of a linear predictor z was analyzed in the TC group, non-TC group, as well as in patients with diffuse and nodular diseases of the thyroid and subgroups with stage T1a–4 tumors. Results. The final multivariate logistic model included a limited set of independent demographic, anthropometric, and anamnestic predictors and demonstrated satisfactory discriminating ability with acceptable AUC values per internal validation. Distribution of the linear predictor showed increase in z values in patients with TC. Small range of values of this parameter was predominantly observed in patients without TC, presence of marked "grey area" – in patients with diffuse and nodular thyroid diseases. Comparison of T categories did not show clear correlation between T stage and the value of the linear predictor. Conclusion. The multivariate logistic model developed based in clinical and anamnestic data of the Altai patients allows to identify 3 areas of linear predictor z values corresponding to low, intermediate, and high TC risks. Its application in clinical practice can promote rationalization of examination volume and identification of priority groups for in-depth diagnostics in regions with high TC morbidity.
- 9 June 2026
- Published by Publishing House ABV Press in Head and Neck Tumors (HNT)
- Vol. 16 (1) , 76-83
Prediction of thyroid cancer based on a multifactorial logistic model and the distribution of the linear predictor
Introduction. Altai region has high incidence of thyroid cancer (TC) which served as motivation for development of a multivariable logistic prognostic model based on clinical and amnestic patient data with determination of low, intermediate, and high risks of the disease. The use of the model in clinical practice can promote optimization of examination volume and formation of priority groups for in-depth diagnostics. Aim. To evaluate diagnostic value of a multivariable logistic model for TC prognosis and analyze distribution of a linear predictor in various clinical groups for identification of areas of low, intermediate and high risks. Materials and methods. Single-center retrospective study including 1463 patients with diseases of the thyroid was conducted. The main group consisted of 505 sequentially examined and surgically treated patients with morphologically confirmed TC; the control group included 958 patients without oncological pathology of the thyroid (operated due to suspicion of a tumor with subsequent morphological exclusion and selected during prophylactic examinations). The set of clinical-anamnestic, anthropometric, and phenotypic characteristics was formed based on the results of previously published study on TC risk factors in the Altai population. Using survey patient data, a set of characteristics Х1–X26 was composed. Statistical analysis included descriptive statistics, univariate logistic analysis with categorization of quantitative variables per ROC criteria, as well as development of a multivariate logistic model with stepwise predictor selection. For the final model, χ2 test, area under the ROC curve (AUC), sensitivity and specificity at optimal threshold were assessed; internal validation was performed using the bootsrap method. For clinical interpretation, distribution of a linear predictor z was analyzed in the TC group, non-TC group, as well as in patients with diffuse and nodular diseases of the thyroid and subgroups with stage T1a–4 tumors. Results. The final multivariate logistic model included a limited set of independent demographic, anthropometric, and anamnestic predictors and demonstrated satisfactory discriminating ability with acceptable AUC values per internal validation. Distribution of the linear predictor showed increase in z values in patients with TC. Small range of values of this parameter was predominantly observed in patients without TC, presence of marked "grey area" – in patients with diffuse and nodular thyroid diseases. Comparison of T categories did not show clear correlation between T stage and the value of the linear predictor. Conclusion. The multivariate logistic model developed based in clinical and anamnestic data of the Altai patients allows to identify 3 areas of linear predictor z values corresponding to low, intermediate, and high TC risks. Its application in clinical practice can promote rationalization of examination volume and identification of priority groups for in-depth diagnostics in regions with high TC morbidity.
- Open Access
- 1 January 2026
- Published by Altay State Medical University in Bulletin of Medical Science
- Vol. 38 (1) , 81-86
BICYCLE ERGOMETRIC TEST RESULTS IN ASYMPTOMATIC PATIENTS WITH ALBUMINURIA
Objective. The purpose of the study was to evaluate the possible association between urinary albumin excretion and exercise stress test results in asymptomatic patients. Materials and Methods. This continuous study included 62 asymptomatic patients, mean age 51.0 ± 9.6 years, who had undergone exercise testing and had a negative VEM test. All patients underwent a general clinical examination. Urine albumin and creatinine levels were determined by calculating the albumin/creatinine ratio (mg/day). The glomerular filtration rate (SFR) was calculated using creatinine using the CKD-EPI formula (ml/min/1.73 m2). The VEM test was performed using the Valenta hardware and software system (Russia, St. Petersburg) version 1.4.4 using a stepwise, continuously increasing test with a pedal speed of 60 rpm in an upright position. Based on albuminuria levels, patients were divided into two groups: Group 1 (n = 48) – individuals without albuminuria; Group 2 (n = 19) – individuals with albuminuria (albumin/creatinine ratio greater than 30 mg/s). Data analysis was performed with R Studio version 4.5.1. A p < 0.05 was considered statistically significant. Results. Patients in both groups had a comparable mean age, rates of hypertension, obesity, smoking, resting tachycardia, and an early family history. Diabetes mellitus was 3.7 times more common in Group 2 (χ² = 5.793, p = 0.017). No differences were found in SCF between Groups 1 and 2. Albuminuria levels were 1.6 times higher in Group 2 (p = 0.001) compared to Group 1. Patients in Groups 1 and 2 had comparable values for maximum power, total work, and maximum oxygen consumption. Patients in Group 1, compared to Group 2, had a 2.5 – fold higher rate of arrhythmia during the recovery period of the exercise stress test (χ² = 5.191, p = 0.023). Conclusion. Asymptomatic patients with albuminuria have physical performance indicators to controls; however, they are characterized by a higher rate of arrhythmia during the recovery period of the exercise stress test. In our opinion, this requires additional research to more accurately stratify the risk of coronary heart disease and assess the long-term prognosis in this population of patients.
- 1 January 2026
- Published by Altay State Medical University in Bulletin of Medical Science
- Vol. 38 (1) , 81-86
Open AccessBICYCLE ERGOMETRIC TEST RESULTS IN ASYMPTOMATIC PATIENTS WITH ALBUMINURIA
Objective. The purpose of the study was to evaluate the possible association between urinary albumin excretion and exercise stress test results in asymptomatic patients. Materials and Methods. This continuous study included 62 asymptomatic patients, mean age 51.0 ± 9.6 years, who had undergone exercise testing and had a negative VEM test. All patients underwent a general clinical examination. Urine albumin and creatinine levels were determined by calculating the albumin/creatinine ratio (mg/day). The glomerular filtration rate (SFR) was calculated using creatinine using the CKD-EPI formula (ml/min/1.73 m2). The VEM test was performed using the Valenta hardware and software system (Russia, St. Petersburg) version 1.4.4 using a stepwise, continuously increasing test with a pedal speed of 60 rpm in an upright position. Based on albuminuria levels, patients were divided into two groups: Group 1 (n = 48) – individuals without albuminuria; Group 2 (n = 19) – individuals with albuminuria (albumin/creatinine ratio greater than 30 mg/s). Data analysis was performed with R Studio version 4.5.1. A p < 0.05 was considered statistically significant. Results. Patients in both groups had a comparable mean age, rates of hypertension, obesity, smoking, resting tachycardia, and an early family history. Diabetes mellitus was 3.7 times more common in Group 2 (χ² = 5.793, p = 0.017). No differences were found in SCF between Groups 1 and 2. Albuminuria levels were 1.6 times higher in Group 2 (p = 0.001) compared to Group 1. Patients in Groups 1 and 2 had comparable values for maximum power, total work, and maximum oxygen consumption. Patients in Group 1, compared to Group 2, had a 2.5 – fold higher rate of arrhythmia during the recovery period of the exercise stress test (χ² = 5.191, p = 0.023). Conclusion. Asymptomatic patients with albuminuria have physical performance indicators to controls; however, they are characterized by a higher rate of arrhythmia during the recovery period of the exercise stress test. In our opinion, this requires additional research to more accurately stratify the risk of coronary heart disease and assess the long-term prognosis in this population of patients.
- Open Access
- 9 July 2025
- Published by Publishing House ABV Press in Head and Neck Tumors (HNT)
- Vol. 15 (2) , 75-84
Prognostic significance of the Bethesda cytological classification in recurrent thyroid carcinoma
Introduction. The Bethesda System for Reporting Thyroid Cytopathology allows to standardize interpretation of fine needle aspiration biopsy of thyroid nodules with assessment of suspected malignancy risk. Analysis of prognostic significance of cytological data, using the Bethesda System as an example, is necessary for determination of tumor process aggressiveness and possibility of development of recurrences.Aim. To study prognostic significance of the Bethesda System for Reporting Thyroid Cytopathology in recurrent thyroid carcinoma.Materials and methods. Results of examinations and surgical interventions performed at the Altai Regional Oncological Dispensary (Barnaul) during a 3-year period in 503 patients (423 women (84.1 %) and 80 (15.9 %) men) with thyroid carcinoma are analyzed. In 440 patients, thyroid carcinoma in surgical material was found for the first time (R0 – primary patients); in 63 patients, disease recurrence was diagnosed (R1 – presence of recurrence). At the time of surgery, median patient age was 51 years (interquartile range 40–62 years). The inclusion criterion for the study was morphologically confirmed diagnosis of thyroid carcinoma; the exclusion criterion was the absence of cytological examination per the Bethesda System in patients with recurrent carcinoma. Data from medical records, disease histories and cancer registry were evaluated taking into account clinical and anamnestic characteristics of a special classifier for determination of risk factors of disease recurrence. Data processing was performed using Microsoft Excel software. At the preoperative stage, in primary patients, results of ultrasound and cytological examination of the fine needle aspiration biopsy of thyroid nodules were analyzed. Results of cytological examination per the Bethesda System were considered as an independent risk factor of recurrence. Orange Data Mining (version 3.3.37.0) and RStudio (version 4.3.1) software were used for data analysis. Distributions of quantitative variables were evaluated using the Kolmogorov–Smirnov and Shapiro–Wilk tests. Normal distribution hypothesis was rejected at p 0.20 for Kolmogorov–Smirnov test and at p 0.05 for Shapiro–Wilk test.Results. According to the data, median time to recurrence was 2 years (Q1–Q3 – 1–6 years), minimal time to its development was 1 year, maximal – 20 years. 1-year recurrence-free survival was 100 %, 3-year was 91 %, 5-year was 86 %, 10-year was 59 %, 15-year was 25 %. Mean time to recurrence in 50 % of patients was 9.8 ± 0.9 years. Risk of recurrence of thyroid carcinoma of category IV per the Bethesda System was 3.623 times (72.4 %) lower compared to category III (hazard ratio 0.276; 95 % confidence interval 0.110–0.691; p = 0.006). Recurrence-free survival in patients with thyroid carcinoma of category VI per the Bethesda System was significantly higher (р = 0003 and p 0.001) than in patients with category III and IV cytopathology.Conclusion. Cytological conclusion of category III per the Bethesda System is 2.755 times more common in recurrence group than of category VI. Category VI cytopathology, 88.7 % of which are papillary thyroid carcinoma with conclusive cell signs, is characterized by relatively low risk of recurrence. Cytologic conclusion of categories III and IV per the Bethesda System is an unfavorable prognostic factor in preoperative diagnostics due to undetermined interpretation of the pathology. These categories are commonly observed in patients with more aggressive disease progression.
- 9 July 2025
- Published by Publishing House ABV Press in Head and Neck Tumors (HNT)
- Vol. 15 (2) , 75-84
Open AccessPrognostic significance of the Bethesda cytological classification in recurrent thyroid carcinoma
Introduction. The Bethesda System for Reporting Thyroid Cytopathology allows to standardize interpretation of fine needle aspiration biopsy of thyroid nodules with assessment of suspected malignancy risk. Analysis of prognostic significance of cytological data, using the Bethesda System as an example, is necessary for determination of tumor process aggressiveness and possibility of development of recurrences.Aim. To study prognostic significance of the Bethesda System for Reporting Thyroid Cytopathology in recurrent thyroid carcinoma.Materials and methods. Results of examinations and surgical interventions performed at the Altai Regional Oncological Dispensary (Barnaul) during a 3-year period in 503 patients (423 women (84.1 %) and 80 (15.9 %) men) with thyroid carcinoma are analyzed. In 440 patients, thyroid carcinoma in surgical material was found for the first time (R0 – primary patients); in 63 patients, disease recurrence was diagnosed (R1 – presence of recurrence). At the time of surgery, median patient age was 51 years (interquartile range 40–62 years). The inclusion criterion for the study was morphologically confirmed diagnosis of thyroid carcinoma; the exclusion criterion was the absence of cytological examination per the Bethesda System in patients with recurrent carcinoma. Data from medical records, disease histories and cancer registry were evaluated taking into account clinical and anamnestic characteristics of a special classifier for determination of risk factors of disease recurrence. Data processing was performed using Microsoft Excel software. At the preoperative stage, in primary patients, results of ultrasound and cytological examination of the fine needle aspiration biopsy of thyroid nodules were analyzed. Results of cytological examination per the Bethesda System were considered as an independent risk factor of recurrence. Orange Data Mining (version 3.3.37.0) and RStudio (version 4.3.1) software were used for data analysis. Distributions of quantitative variables were evaluated using the Kolmogorov–Smirnov and Shapiro–Wilk tests. Normal distribution hypothesis was rejected at p 0.20 for Kolmogorov–Smirnov test and at p 0.05 for Shapiro–Wilk test.Results. According to the data, median time to recurrence was 2 years (Q1–Q3 – 1–6 years), minimal time to its development was 1 year, maximal – 20 years. 1-year recurrence-free survival was 100 %, 3-year was 91 %, 5-year was 86 %, 10-year was 59 %, 15-year was 25 %. Mean time to recurrence in 50 % of patients was 9.8 ± 0.9 years. Risk of recurrence of thyroid carcinoma of category IV per the Bethesda System was 3.623 times (72.4 %) lower compared to category III (hazard ratio 0.276; 95 % confidence interval 0.110–0.691; p = 0.006). Recurrence-free survival in patients with thyroid carcinoma of category VI per the Bethesda System was significantly higher (р = 0003 and p 0.001) than in patients with category III and IV cytopathology.Conclusion. Cytological conclusion of category III per the Bethesda System is 2.755 times more common in recurrence group than of category VI. Category VI cytopathology, 88.7 % of which are papillary thyroid carcinoma with conclusive cell signs, is characterized by relatively low risk of recurrence. Cytologic conclusion of categories III and IV per the Bethesda System is an unfavorable prognostic factor in preoperative diagnostics due to undetermined interpretation of the pathology. These categories are commonly observed in patients with more aggressive disease progression.